Skip to main content
. 2018 Dec 15;8(4):95. doi: 10.3390/metabo8040095

Figure 1.

Figure 1

Comparison of (a) normal and (b) Adriamycin (ADR)-treated MCF7 cells stained for SA-β-gal activity. ADR-treated cells were larger and had a flatter morphology than untreated cells. Cell counting (250 cells per condition) showed that the number of SA-β-gal-positive (blue) cells versus the number of total cells was approximately 4% in the untreated cells and ~60% in the treated cells.